The role of the PTEN gene in malignant gliomas

Neurologia i Neurochirurgia Polska

Volumn 44, Issue 1, 2010, Pages 80-86

  Alexiou, George A ^a   Voulgaris, Spyridon ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

Author keywords

AKT; Glioma; PTEN

Indexed keywords

MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53;

ANGIOGENESIS; CANCER INVASION; CELL CYCLE PROGRESSION; CELL MIGRATION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 77951290869     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0028-3843(14)60408-4     Document Type: Review

References (78)

1. Buckner J.C. Factors influencing survival in high-grade gliomas. Semin Oncol 2003; 30: 10-14.
2. Nabors L.B., Fiveash J. Treatment of adults with recurrent malignant glioma. Expert Rev Neurother 2005; 5: 509-514.
3. Furnari F.B., Fenton T., Bachoo R.M., et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21: 2683-2710.
4. Li J., Simpson L., Takahashi M., et al. The Pten/MMAC1 tumor suppressor induces cell death that is rescued by the Akt/protein kinase B oncogene. Cancer Res 1997; 58: 5667-5672.
5. Li D.M., Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57: 2124-2129.
6. Li J., Yen C., Liaw D., et al. PTEN: a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
7. Cully M., You H., Levine A.J., et al. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 2006; 6: 184-192.
8. Duerr E.M., Rollbrocker B., Hayashi Y., et al. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998; 16: 2259-2264.
9. Levitt R.J., Georgescu M.M., Pollak M. PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Biochem Biophys Res Commun 2005; 336: 1056-1061.
10. Blanco-Aparicio C., Renner O., Leal J.F., et al. PTEN, more than the AKT pathway. Carcinogenesis 2007; 28: 1379-1386.
11. Mairet-Coello G., Tury A., DiCicco-Bloom E. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J Neurosci 2009; 29: 775-788.
12. Fuller G.N., Rhee C.H., Hess K.R., et al. Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res 1999; 13: 4228-4232.
13. Godard S., Getz G.M., Delorenzi P., et al. Classification of human astrocytic gliomas on the basis of gene expression: a correlated group of genes with angiogenic activity emerges as a strong predictor of subtypes. Cancer Res 2003; 63: 6613-6625.
14. Levine A.J., Finlay C.A., Hinds P.W. P53 is a tumor suppressor gene. Cell 2004; 23: 116.
15. Stambolic V., MacPherson D., Sas D., et al. Regulation of PTEN transcription by p53. Mol Cell 2001; 8: 317-325.
16. Chappell W.H., Green T.D., Spengeman J.D., et al. Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1. Cell Cycle 2005; 4: 1389-1395.
17. Tang Y., Eng C. p53 down-regulates phosphatase and tensin homologue deleted on chromosome 10 protein stability partially through caspase-mediated degradation in cells with proteasome dysfunction. Cancer Res 2006; 66: 6139-6148.
18. Lewis B.P., Shih I.H., Jones-Rhoades M.W., et al. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
19. Meng F., Henson R., Lang M., et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113-2129.
20. Bueno M.J., de Castro I.P., Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008; 7: 3143-3148.
21. Huse J.T., Brennan C., Hambardzumyan D., et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327-1337.
22. Sano T., Lin H., Chen X., et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res 1999; 59: 1820-1824.
23. Perren A., Weng L.P., Boag A.H., et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 1999; 155: 1253-1260.
24. Dreher T., Zentgraf H., Abel U., et al. Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies. Virchows Arch 2004; 444: 509-517.
25. Perren A., Komminoth P., Saremaslani P., et al. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 2000; 157: 1097-1103.
26. Liu F., Wagner S., Campbell R.B., et al. PTEN enters the nucleus by diffusion. J Cell Biockem 2005; 96: 221-234.
27. Chang C.J., Mulholland D.J., Valamehr B., et al. PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression. Mol Cell Biol 2008; 28: 3281-3289.
28. Chung JH., Ginn-Pease M.E., Eng C. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 2005; 65: 4108-4116.
29. Minaguchi T., Waite K.A., Eng C. Nuclear localization of PTEN is regulated by Ca(2+) through a tyrosil phosphorylation-independent conformational modification in major vault protein. Cancer Res 2006; 66: 11677-11682.
30. Trotman L.C., Wang X., Alimonti A., et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128: 141-156.
31. Planchon S.M., Waite K.A., Eng C. The nuclear affairs of PTEN. J Cell Sci 2008; 121: 249-253.
32. Liu J.L., Sheng X., Hortobagyi Z.K., et al. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol 2005; 25: 6211-6224.
33. Gil A., Andrés-Pons A., Fernández E., et al. Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: Involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell 2006; 17: 4002-4013.
34. Fraser M.M., Zhu X., Kwon C.H., et al. PTEN loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 2004; 64: 7773-17739
35. Cheney I.W., Johnson D.E., Vaillancourt M.T., et al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 1998; 58: 2331-2334.
36. Furnari F.B., Lin H., Huang H.S., et al. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A 1997; 94: 12479-12484.
37. Furnari F.B., Huang H.J., Cavenee W.K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 1998; 58: 5002-5008.
38. Li D.M., Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci U S A 1998; 95: 15406-15411.
39. Gottschalk A.R., Basila D., Wong M., et al. p27Kip1 is required for PTEN-induced G1 growth arrest. Cancer Res 2001; 61: 2105-2111.
40. Cheney I.W., Neuteboom S.T., Vaillancourt M.T., et al. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res 1999; 59: 2318-2323.
41. Lee J.Y., Kang M.B., Jang S.H., et al. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 2009; 28: 824-831.
42. Castellino R.C., Durden D.L. Mechanisms of disease: the PI3K-Akt-PTEN signaling node - an intercept point for the control of angiogenesis in brain tumors. Nat Clin Pract Neurol 2007; 3: 682-693.
43. Wen S., Stolarov J., Myers M.P., et al. PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci U S A 2001; 98: 4622-4627.
44. Su J.D., Mayo L.D., Donner D.B., et al. PTEN and phosphatidylinositol 3′-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res 2003; 63: 3585-3592.
45. Dameron K.M., Volpert O.V., Tainsky M.A., et al. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265: 1582-1584.
46. Schofield C.J., Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
47. Laughner E., Taghavi P., Chiles K., et al. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995-4004.
48. Zhong H., Chiles K., Feldser D., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541-1545.
49. Zundel W., Schindler C., Haas-Kogan D., et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 2000; 14: 391-396.
50. Jiang B.H., Jiang G., Zheng J.Z., et al. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ 2001; 12: 363-369.
51. Emerling B.M., Weinberg F., Liu J.L., et al. PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci U S A 2008; 105: 2622-2627.
52. Beckner M.E., Chen X., An J., et al. Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab Invest 2005; 85: 316-327.
53. Elstrom R.L., Bauer D.E., Buzzai M., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004; 64: 3892-3899.
54. Lu H., Dalgard C.L., Mohyeldin A., et al. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 2005; 280: 41928-41939.
55. Lu H., Forbes R.A., Verma A. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 2002; 277: 23111-23115.
56. Hunt T.K., Aslam R.S., Beckert S., et al. Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxid Redox Signal 2001; 9: 1115-1124.
57. Liotta L.A., Rao C.N., Wewer U.M. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55: 1037-1057.
58. Tamura M., Gu J., Matsumoto K., et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614-1617.
59. Furukawa K., Kumon Y., Harada H., et al. PTEN gene transfer suppresses the invasive potential of human malignant gliomas by regulating cell invasion-related molecules. Int J Oncol 2006; 29: 73-81.
60. Liliental J., Moon S.Y., Lesche R., et al. Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 2000; 10: 401-404.
61. Raftopoulou M., Etienne-Manneville S., Self A., et al. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 2004; 303: 1179-1181.
62. Leslie N.R., Yang X., Downes C.P., et al. PtdIns(3,4,5)P(3)-dependent and independent roles for PTEN in the control of cell migration. Curr Biol 2007; 17: 115-125.
63. Dey N., Crosswell H.E., De P., et al. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 2008; 68: 1862-1871.
64. Wheeler A.P., Ridley A.J. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 2004; 301: 43-49.
65. Baldwin R.M., Parolin D.A., Lorimer I.A. Regulation of glioblastoma cell invasion by PKC iota and RhoB. Oncogene 2008; 27: 3587-3595.
66. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
67. Groszer M., Erickson R., Scripture-Adams D.D., et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 2001; 294: 2186-2189.
68. Li L., Liu F., Salmonsen R.A., et al. PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci 2002; 20: 21-29.
69. Groszer M., Erickson R., Scripture-Adams D.D., et al. PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A 2006; 103: 111-116.
70. Sinor A.D., Lillien L. Akt-1 expression level regulates CNS precursors. J Neurosci 2004; 24: 8531-8541.
71. Otaegi G., Yusta-Boyo M.J., Vergaño-Vera E., et al. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells. J Cell Sci 2006; 119: 2739-2748.
72. Yue Q., Groszer M., Gil J.S., et al. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 2005; 132: 3281-3291.
73. Kwon C.H., Zhao D., Chen J., et al. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008; 68: 3286-3294.
74. Smith J.S., Tachibana I., Passe S.M., et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 2001; 93: 1246-1256.
75. Sasaki H., Zlatescu M.C., Betensky R.A., et al. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. Am J Pathol 2001; 159: 359-367.
76. Ermoian R.P., Furniss C.S., Lamborn K.R., et al. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Clin Cancer Res 2002; 8: 1100-1106.
77. Raffel C., Frederick L., O'Fallon J.R., et al. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin Cancer Res 1999; 5: 4085-4090.
78. Thorarinsdottir H.K., Santi M., McCarter R., et al. Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas. Clin Cancer Res 2008; 14: 3386-3394.